Because IDH-mutant infiltrating astrocytoma also commonly harbor TP53 and ATRX mutations, these genes can act as additional markers for distinguishing between IDH-mutated astrocytomas and oligodendrogliomas. This evidence concerns the gene ATRX and astrocytoma (excluding glioblastoma).